Cybin Demonstrates Proof of Concept of its Deuterated Tryptamines for the Treatment of Depression and Addiction

CANNANNEW REPORT

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has successfully demonstrated… Read More…..

Excerpt only …
READ MORE BELOW
Source : Cybin Demonstrates Proof of Concept of its Deuterated Tryptamines for the Treatment of Depression and Addiction

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.